|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07J 43/00 | (2006.01) |
| A61K 31/575 | (2013.01) | ||
| C07J 31/00 | (2006.01) | ||
| A61K 31/58 | (2013.01) | ||
| C07J 43/003 | (2013.01) | ||
| C07J 33/00 | (2006.01) | ||
| C07J 33/002 | (2013.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61K 31/58 | (2006.01) | ||
| C07J 9/005 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| C07J 9/00 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| C07J 41/0061 | (2013.01) | ||
| A61P 13/02 | (2006.01) | ||
| C07J 17/00 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| C07J 41/0094 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 13/02 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| C07J 9/00 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| C07J 17/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| C07J 41/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Patento numeris | 3409684 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17743740.7 |
| Europos patento paraiškos padavimo data | 2017-01-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2017/072567 |
| Data | 2017-01-25 |
| (87) | Numeris | WO 2017/129125 |
| Data | 2017-08-03 |
| (30) | Numeris | Data | Šalis |
| 201610061293 | 2016-01-28 | CN | |
| 201610331759 | 2016-05-18 | CN |
| (72) |
HE, Haiying , CN
XIAO, Hualing , CN
LI, Peng , CN
DU, Chunyan , CN
LUO, Zhi , CN
CHEN, Shuhui , CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ,
No. 369 Yuzhou South Rd., Lianyungang, Jiangsu 222062,
CN
|
| (54) | STEROID DERIVATIVE FXR AGONIST |
| STEROID DERIVATIVE FXR AGONIST |